Here is a hub for 2017 stem cell and regenerative medicine meetings. If you do not see your meeting, please let me know and I will include it. Change– I’m also going to be listing online courses (in red) this year. This list is meant to be as inclusive as possible, but by listing specific […]
Stem Cell Meetings & Conferences 2017 Read More »
For better or worse, I am in the unique position of being a stem cell scientist and also a former cancer patient. Looking on the bright side this gives me a unique perspective on things compared to many of my colleagues. I know there are thousands of people out there looking for more practical information
Patients guide to stem cell treatments for 2021 Read More »
ISSCR 2016’s first plenary session is focused on stem cells & cancer. I was really excited about this one even before the meeting as this topic is a major focus of my own lab. Here’s the lineup for this plenary with great expertise in stem cells & cancer from across the globe: President’s Address: Sean Morrison, Children’s
Austin Smith talk at ISSCR 2016: a ground state inhibitor pathway Read More »
The REGROW Act would drastically weaken FDA regulation of experimental stem cell therapies. I’ve criticized it in numerous posts (see those here) for its radical ideas that would put patients and the stem cell field at risk. I’m not the only one concerned about it as both ARM and ISSCR oppose it too. Now 10 top patient advocacy
Ten patient groups oppose REGROW Act that would gut stem cell oversight Read More »
A committee of the International Society for Stem Cell Research (ISSCR) did one heck of a document dump yesterday on stem cell policy, releasing a whole bunch of policy recommendations on stem cells and more. The torrent from ISSCR included a 37-page policy statement itself as well as several papers in top journals including the
ISSCR Releases Flood of Stem Cell Policy Docs Read More »
What is direct reprogramming ? There’s some big, positive news on this stem cell front today. All chemical direct reprogramming Two new innovative papers both by teams led by Sheng Ding of Gladstone Institutes with UCSF report all-chemical direct reprogramming of human somatic cells. Ding’s team took skin cells and by exposing them to cocktails of
Big stem cell news: dynamic duo of all-chemical direct reprogramming reports Read More »
I talked last year about human genetic modification by CRISPR with George Church a year ago. Now we’ve followed up with a long chat on this topic going into much more detail and with questions on recent developments. Each question is listed numerically and then there is a back and forth on that question with George
George Church chat: CRISPR people, Zika, weapons Read More »
The number of people around the world being injected with stem cells every day has never been higher and the heterogeneous group of medical providers doing these procedures is also at or near its highest level ever. The cells used are also highly variable as are the procedures themselves, but most of these cells fall under the
Review of Centeno MSC safety paper: without controls, conclusions muted Read More »
The Capitol Times in Wisconsin ran a story just before the primary there on Bernie Sanders on Stem Cells, indicating that has held anti-stem cell research positions. It can sometimes be hard to figure out politicians’ positions on stem cells and what actions they might take. Update: See this poll on what people predicted the
Bernie Sanders Mixed Record on Stem Cells Read More »
Traditional clinical trials have four phases. Each phase plays an important, unique role in testing whether new drug products are safe and effective as well as how they compare to the standard of care. Today in the stem cell field across the globe, the Phase III is under fire including what some might call friendly
Important, endangered species in stem cell medicine: the phase III trial Read More »